Skip to content

Clinical study of comprehensive therapy in the treatment of subjective tinnitus

Clinical study of comprehensive therapy in the treatment of subjective tinnitus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014731
Enrollment
Unknown
Registered
2017-12-26
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjective tinnitus

Interventions

treatment group:Acupoint injection therapy combined with Acupuncture

Sponsors

Huadong Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patients were in accordance with the criteria of subjective tinnitus; 2. The patients have persistent tinnitus (unilateral or bilateral) as the main symptom, accompanied by or without hearing loss, insomnia and other symptoms; 3. Course of disease in 3 years; 4. Aged 18-70 years old, can be very good to describe and express their own condition, gender not limited; 5. The patients are willing to accept the treatment scheme and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who had a course of more than 3 years;The patients age were less than 18 or more than 70 years old; 2. Objectivity tinnitus caused by vascular malformation and myoclonus. 3. Patients with severe systemic systemic disease; 4. Patients with severe mental illness or pregnancy or lactation; 5. People who can not accept water needle therapy or acupuncture treatment; 6. Patients who would not accept the treatment of this study.

Design outcomes

Primary

MeasureTime frame
Tinnitus severity score;

Secondary

MeasureTime frame
Tinnitus disability assessment scale;

Countries

China

Contacts

Public ContactMo Wenquan

Huadong Hospital

mowenquan@hotmail.com+86 13816623514

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026